Article: Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease.(Clinical report)

Findings May Complement Current Clinical Practices for Assessing Risk of CHD

Findings Based on a Population-Based Prospective Study of Nearly 10,000 Individuals and Two Independent Case-Control Studies Involving Nearly 3,000 Individuals

ALAMEDA, Calif. -- Celera (NYSE:CRA), an Applera Corporation business, today announced the publication of results from the Atherosclerosis Risk in Communities (ARIC) study and two independent case-control studies describing the development of a Genetic Risk Score[TM] (GRS) based on five gene variants that predicts risk for coronary heart disease (CHD). These variant genes were KIF6, MYH15, PALLD, SNX19, and VAMP8. The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!